Louise Ghesquière
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Louise Ghesquière has a total of 157 co-authors. Here are the top co-authors by number of shared publications:
Charles Garabedian
ULR 2694—METRICS—Evaluation des technologies de santé et des pratiques médicales CHU Lille, Université Lille Lille France
9 shared publicationsC. Garabedian
Univ. Lille, CHU Lille, ULR 2694-METRICS-Evaluation des technologies de santé et des pratiques médicales, Lille, France
8 shared publications- Charles Garabedian
Department of Obstetrics CHU Lille Lille France
5 shared publications Damien Subtil
Department of Obstetrics, CHU Lille, Lille F-59000, France; ULR 2694 - METRICS - Health Technology and Medical Practice Assessment, Univ. Lille, CHU Lille, Lille F-59000, France
4 shared publicationsDyuti Sharma
ULR 2694—METRICS—Evaluation des technologies de santé et des pratiques médicales CHU Lille, Université Lille Lille France
4 shared publicationsLaurent Storme
ULR 2694—METRICS—Evaluation des technologies de santé et des pratiques médicales CHU Lille, Université Lille Lille France
4 shared publications
Latest Publications
- Open Access
- 17 January 2025
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 88, 127601
Iodine intakes of pregnant females from Québec, Canada
- 17 January 2025
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 88, 127601
Open AccessIodine intakes of pregnant females from Québec, Canada
- Open Access
- 26 September 2024
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 103 (11) , 2281-2288
How does fetal inflammatory response syndrome change fetal response to hypoxia? An experimental study in a fetal sheep model
Introduction: Fetal inflammatory response syndrome associated with acidosis during labor is a high‐risk situation for the fetus. This study evaluated hemodynamic, gasometric, and heart rate variability changes during acute fetal inflammatory response syndrome associated with hypoxia, compared with isolated hypoxia.Material and Methods: Acute fetal inflammatory response syndrome was obtained via an intravenously injection of lipopolysaccharide derived from Escherichia coli. Hypoxia was induced by repeated umbilical cord occlusions during three phases: mild, moderate, and severe umbilical cord occlusions. Two groups were created with chronically instrumented near‐term fetal sheep: one group with isolated hypoxia, the other with hypoxia and fetal inflammatory response syndrome. Hemodynamic, gas parameters, and fetal heart rate variability were compared between the groups.Results: The hypoxia and fetal inflammatory response syndrome group had a higher mortality rate (n = 4/9) compared with the hypoxia group (n = 0/9). Gasometric state was altered earlier in case of lipopolysaccharide injection (pH = 7.22 (7.12–7.24) vs 7.28 (7.23–7.34) p = 0.01; lactate = 10.3 mmol/L (9.4–11.0) vs 6.0 mmol/L (4.1–8.2) p < 0.001 after mild occlusions). After mild occlusions, the hypoxia and fetal inflammatory response syndrome group had higher values on seven heart rate variability parameters compared with the hypoxia group. After moderate occlusions, two parameters remained significantly higher.Conclusions: During fetal inflammatory response syndrome, fetal adaptation to hypoxia is impaired. In case of fetal infection, acidosis during labor is likely to become severe more rapidly, requiring closer fetal monitoring during labor.
- 26 September 2024
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 103 (11) , 2281-2288
Open AccessHow does fetal inflammatory response syndrome change fetal response to hypoxia? An experimental study in a fetal sheep model
Introduction: Fetal inflammatory response syndrome associated with acidosis during labor is a high‐risk situation for the fetus. This study evaluated hemodynamic, gasometric, and heart rate variability changes during acute fetal inflammatory response syndrome associated with hypoxia, compared with isolated hypoxia.Material and Methods: Acute fetal inflammatory response syndrome was obtained via an intravenously injection of lipopolysaccharide derived from Escherichia coli. Hypoxia was induced by repeated umbilical cord occlusions during three phases: mild, moderate, and severe umbilical cord occlusions. Two groups were created with chronically instrumented near‐term fetal sheep: one group with isolated hypoxia, the other with hypoxia and fetal inflammatory response syndrome. Hemodynamic, gas parameters, and fetal heart rate variability were compared between the groups.Results: The hypoxia and fetal inflammatory response syndrome group had a higher mortality rate (n = 4/9) compared with the hypoxia group (n = 0/9). Gasometric state was altered earlier in case of lipopolysaccharide injection (pH = 7.22 (7.12–7.24) vs 7.28 (7.23–7.34) p = 0.01; lactate = 10.3 mmol/L (9.4–11.0) vs 6.0 mmol/L (4.1–8.2) p < 0.001 after mild occlusions). After mild occlusions, the hypoxia and fetal inflammatory response syndrome group had higher values on seven heart rate variability parameters compared with the hypoxia group. After moderate occlusions, two parameters remained significantly higher.Conclusions: During fetal inflammatory response syndrome, fetal adaptation to hypoxia is impaired. In case of fetal infection, acidosis during labor is likely to become severe more rapidly, requiring closer fetal monitoring during labor.
- Open Access
- 10 February 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (4) , 1022
Aspirin at 75 to 81 mg Daily for the Prevention of Preterm Pre-Eclampsia: Systematic Review and Meta-Analysis
Background: Aspirin at 150 mg daily, initiated in the 1st trimester of pregnancy, prevents preterm pre-eclampsia. We aimed to estimate whether a dose of 75 to 81 mg daily can help to prevent preterm pre-eclampsia as well. Methods: A systematic search was conducted using multiple databases and meta-analyses of randomized controlled trials (RCTs) that compared aspirin initiated in the first trimester of pregnancy to placebo or no treatment, following the PRISMA guidelines and the Cochrane risk of bias tool. Results: We retrieved 11 RCTs involving 13,981 participants. Five RCTs had a low risk of bias, one at unclear risk, and fiver had a high risk of bias. A pooled analysis demonstrated that doses of 75 to 81 mg of aspirin, compared to a placebo or no treatment, was not associated with a significant reduction in preterm pre-eclampsia (8 studies; 12,391 participants; relative risk, 0.66; 95% confidence interval: 0.27 to 1.62; p = 0.36), but there was a significant heterogeneity across the studies (I2 = 61%, p = 0.02). Conclusion: It cannot be concluded that taking 75 to 81 mg of aspirin daily reduces the risk of preterm pre-eclampsia. However, given the significant heterogeneity between the studies, the true effect that such a dose of aspirin would have on pregnancy outcomes could not be properly estimated.
- 10 February 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (4) , 1022
Open AccessAspirin at 75 to 81 mg Daily for the Prevention of Preterm Pre-Eclampsia: Systematic Review and Meta-Analysis
Background: Aspirin at 150 mg daily, initiated in the 1st trimester of pregnancy, prevents preterm pre-eclampsia. We aimed to estimate whether a dose of 75 to 81 mg daily can help to prevent preterm pre-eclampsia as well. Methods: A systematic search was conducted using multiple databases and meta-analyses of randomized controlled trials (RCTs) that compared aspirin initiated in the first trimester of pregnancy to placebo or no treatment, following the PRISMA guidelines and the Cochrane risk of bias tool. Results: We retrieved 11 RCTs involving 13,981 participants. Five RCTs had a low risk of bias, one at unclear risk, and fiver had a high risk of bias. A pooled analysis demonstrated that doses of 75 to 81 mg of aspirin, compared to a placebo or no treatment, was not associated with a significant reduction in preterm pre-eclampsia (8 studies; 12,391 participants; relative risk, 0.66; 95% confidence interval: 0.27 to 1.62; p = 0.36), but there was a significant heterogeneity across the studies (I2 = 61%, p = 0.02). Conclusion: It cannot be concluded that taking 75 to 81 mg of aspirin daily reduces the risk of preterm pre-eclampsia. However, given the significant heterogeneity between the studies, the true effect that such a dose of aspirin would have on pregnancy outcomes could not be properly estimated.
- Open Access
- 30 November 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (11) , e0293926
Early heart rate variability changes during acute fetal inflammatory response syndrome: An experimental study in a fetal sheep model
Introduction: Fetal infection during labor with fetal inflammatory response syndrome (FIRS) is associated with neurodevelopmental disabilities, cerebral palsy, neonatal sepsis, and mortality. Current methods to diagnose FIRS are inadequate. Thus, the study aim was to explore whether fetal heart rate variability (HRV) analysis can be used to detect FIRS. Material and methods: In chronically instrumented near-term fetal sheep, lipopolysaccharide (LPS) was injected intravenously to model FIRS. A control group received saline solution injection. Hemodynamic, blood gas analysis, interleukin-6 (IL-6), and 14 HRV indices were recorded for 6 h. In both groups, comparisons were made between the stability phase and the 6 h following injection (H1–H6, respectively) and between LPS and control groups. Results: Fifteen lambs were instrumented. In the LPS group (n = 8), IL-6 increased significantly after LPS injection (p < 0.001), confirming the FIRS model. Fetal heart rate increased significantly after H5 (p < 0.01). In our FIRS model without shock or cardiovascular decompensation, five HRV measures changed significantly after H2 until H4 in comparison to baseline. Moreover, significant differences between LPS and control groups were observed in HRV measures between H2 and H4. These changes appear to be mediated by an increase of global variability and a loss of signal complexity. Conclusion: As significant HRV changes were detected before FHR increase, these indices may be valuable for early detection of acute FIRS.
- 30 November 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (11) , e0293926
Open AccessEarly heart rate variability changes during acute fetal inflammatory response syndrome: An experimental study in a fetal sheep model
Introduction: Fetal infection during labor with fetal inflammatory response syndrome (FIRS) is associated with neurodevelopmental disabilities, cerebral palsy, neonatal sepsis, and mortality. Current methods to diagnose FIRS are inadequate. Thus, the study aim was to explore whether fetal heart rate variability (HRV) analysis can be used to detect FIRS. Material and methods: In chronically instrumented near-term fetal sheep, lipopolysaccharide (LPS) was injected intravenously to model FIRS. A control group received saline solution injection. Hemodynamic, blood gas analysis, interleukin-6 (IL-6), and 14 HRV indices were recorded for 6 h. In both groups, comparisons were made between the stability phase and the 6 h following injection (H1–H6, respectively) and between LPS and control groups. Results: Fifteen lambs were instrumented. In the LPS group (n = 8), IL-6 increased significantly after LPS injection (p < 0.001), confirming the FIRS model. Fetal heart rate increased significantly after H5 (p < 0.01). In our FIRS model without shock or cardiovascular decompensation, five HRV measures changed significantly after H2 until H4 in comparison to baseline. Moreover, significant differences between LPS and control groups were observed in HRV measures between H2 and H4. These changes appear to be mediated by an increase of global variability and a loss of signal complexity. Conclusion: As significant HRV changes were detected before FHR increase, these indices may be valuable for early detection of acute FIRS.
- 7 June 2023
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 51 (9) , 393-399
Formation initiale par la simulation pour les internes français de gynécologie et obstétrique : état des lieux en 2022
- 7 June 2023
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 51 (9) , 393-399
Formation initiale par la simulation pour les internes français de gynécologie et obstétrique : état des lieux en 2022
- 15 March 2023
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 51 (5) , 270-274
Est-il possible de réduire en sécurité l’utilisation du pH in utero en salle de naissance ? Analyse des pratiques
- 15 March 2023
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 51 (5) , 270-274
Est-il possible de réduire en sécurité l’utilisation du pH in utero en salle de naissance ? Analyse des pratiques
- 26 January 2023
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 282, 155-160
Breech presentation induction compared to cephalic presentation: Effectiveness and characteristics
- 26 January 2023
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 282, 155-160
Breech presentation induction compared to cephalic presentation: Effectiveness and characteristics
- 17 January 2023
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 52 (3) , 102537
Obstetrical outcomes in cases of maternal heart disease with a risk of cardiac decompensation: A retrospective study since the establishment of a multidisciplinary consultation meeting “heart and pregnancy”
- 17 January 2023
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 52 (3) , 102537
Obstetrical outcomes in cases of maternal heart disease with a risk of cardiac decompensation: A retrospective study since the establishment of a multidisciplinary consultation meeting “heart and pregnancy”
- Open Access
- 13 October 2022
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 129 (6) , 937-945
Tranexamic acid dose–response relationship for antifibrinolysis in postpartum haemorrhage during Caesarean delivery: TRACES, a double-blind, placebo-controlled, multicentre, dose-ranging biomarker study
- 13 October 2022
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 129 (6) , 937-945
Open AccessTranexamic acid dose–response relationship for antifibrinolysis in postpartum haemorrhage during Caesarean delivery: TRACES, a double-blind, placebo-controlled, multicentre, dose-ranging biomarker study